Conference weak

This year's JPMorgan Healthcare Conference was marred by the biotech sector's worst conference week performance in more than two decades. But if 2016 is off to a dire start, at least one buysider and a technical analyst want more than two weeks of data before calling the year a disaster.

The BioCentury 100 index shed 6% last week, losing ground during JPM for the first time since a 1% decline in 2005. Since BioCentury began tracking the BC100 in 1993, there had never been a decline of more than 2% during the conference. ...